about
AlloHSCT for inv(3)(q21;q26)/t(3;3)(q21;q26) AML: a report from the acute leukemia working party of the European society for blood and marrow transplantation.Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMTIbrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties"Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries"Late treatment-related mortality versus competing causes of death after allogeneic transplantation for myelodysplastic syndromes and secondary acute myeloid leukemiaClinical impact of clonal hematopoiesis in acute myeloid leukemia patients receiving allogeneic transplantationThe HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapyCorrection: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countriesNarrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trendsFludarabine/busulfan versus fludarabine/total-body-irradiation (2 Gy) as conditioning prior to allogeneic stem cell transplantation in patients (≥60 years) with acute myelogenous leukemia: a study of the acute leukemia working party of the EBMTPrognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM RegistryPredicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurementAuthor Correction: Predicting hepatic complications of allogeneic hematopoietic stem cell transplantation using liver stiffness measurementUse of busulfan in conditioning for allogeneic hematopoietic stem cell transplantation in adults: a survey by the Transplant Complications Working Party of the EBMTRituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experienceWorldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
P50
Q52718440-C4B0C868-5A31-4BA5-B777-F5C33A31B326Q58553367-F0E81F97-D1E6-4845-B5FE-22CBDBB1D945Q59620406-40CBBA91-C9FF-4A2F-B36B-9D255EF833BBQ64115878-B72B4B12-1D0E-4909-AC1D-11FC4C125D46Q64119387-68752DD0-8831-413E-8F85-147CAC99CC0FQ90036340-2DBBB73D-95AD-49DD-B8EC-CD10214237E9Q90365553-C8E6D067-9150-4471-9ED8-98684839B3EEQ90731229-CD7F0A7D-8704-4745-9A8C-E71BA9FAB3E6Q90788440-676A1B04-35B7-41C0-BBC7-87722CF9BC3EQ90911373-18CBF56B-CC13-496E-B3E6-34B9CA70FB61Q91330107-302E1A0D-9CE4-48E4-AC52-299EF8A7ACFCQ91945705-15BB4511-C3D1-41F9-842C-9D65EBE6930EQ92488812-AFC62A96-385F-45A0-8280-0112D428257FQ92503478-86F7E401-3826-4C8E-80B9-CB9F73E367FDQ93087453-0C66BF04-5A4C-4DCD-9798-90318B527D26Q93106889-3C4D8B3B-73EE-4FCF-8ECC-D70FB0811403
P50
description
researcher
@en
name
Dietger Niederwieser
@en
type
label
Dietger Niederwieser
@en
prefLabel
Dietger Niederwieser
@en
P31
P496
0000-0002-4737-1103